RSUP Fatmawati and PT Swayasa Prakarsa Strengthen Collaboration in the Utilization of Medical Consumables

Jakarta, April 14, 2026 — RSUP Fatmawati continues to reinforce its role as a strategic partner in the development and downstreaming of domestic healthcare products through its collaboration with PT Swayasa Prakarsa. This partnership has successfully produced an innovative product that has obtained market authorization and is now widely used, namely Handrub TOP Clean RSF.

The collaboration between RSUP Fatmawati and PT Swayasa Prakarsa encompasses several critical stages, including regulatory approval processes, manufacturing, and the fulfillment of the hospital’s internal needs. Following its success, the Handrub TOP Clean RSF product is now being marketed more broadly to support the needs of other healthcare facilities.

As part of its ongoing efforts to enhance healthcare services, RSUP Fatmawati organized a Medical Consumables (Bahan Medis Habis Pakai/BMHP) Needs Presentation on Tuesday, April 14, 2026. The event was attended by key hospital officials and leaders of strategic units, including the Head of the Infection Prevention and Control Committee, the Head of the Nursing Committee and KTKL, medical and nursing service managers, as well as heads of various departments such as pharmacy, procurement, central surgery, emergency, inpatient, intensive care, central sterilization, and laundry services.

During the session, PT Swayasa Prakarsa presented several flagship medical consumable products, including Inashunt, Ceraspon, Gamacha, medical masks, and the RZ VAC NPWT device. The presentation aimed to introduce product innovations while assessing their suitability for clinical service needs at RSUP Fatmawati.

As a follow-up to the meeting, both parties agreed to conduct product trials for Inashunt, Ceraspon, and Gamacha in accordance with applicable procedures. In addition, a demonstration and trial of the RZ VAC NPWT device will be carried out within RSUP Fatmawati to evaluate its effectiveness and clinical benefits.

Specifically for the Inashunt product trial, PT Swayasa Prakarsa will collaborate with PT Phapros as the official distributor of the INA Shunt product. This collaboration is expected to ensure that the trial process is conducted optimally, in compliance with standards, and capable of generating results that contribute to improving healthcare service quality.

Through this initiative, RSUP Fatmawati and PT Swayasa Prakarsa reaffirm their shared commitment to delivering high-quality, safe, and need-based healthcare innovations, while also supporting the advancement of the domestic medical device industry.